(IVVM) BlackRock Trust II - Large - Overview
Etf: Large-Cap Equities, Buffered Strategy, Non-Diversified
Dividends
| Dividend Yield | 0.68% |
| Yield on Cost 5y | 0.95% |
| Yield CAGR 5y | 25.26% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 12.0% |
| Relative Tail Risk | -0.76% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.66 |
| Alpha | 1.28 |
| Character TTM | |
|---|---|
| Beta | 0.641 |
| Beta Downside | 0.695 |
| Drawdowns 3y | |
|---|---|
| Max DD | 11.62% |
| CAGR/Max DD | 1.21 |
Description: IVVM BlackRock Trust II - Large January 29, 2026
IVVM is a U.S.–based, non-diversified, Defined-Outcome ETF that allocates at least 80 % of its net assets (plus any investment-purpose borrowings) to equity securities of large-cap companies that fall within the capitalization range of its benchmark index. The remaining allocation may be used for cash, derivatives, or other instruments that support the fund’s moderate buffer strategy.
As of the most recent data (January 2026):
• Expense ratio: 0.20 % (BlackRock filing, Q4 2025).
• Buffer structure: 6 % downside protection with a 6 % upside cap for the 2025-2026 outcome period.
• 1-year total return: +4.2 % (vs. S&P 500 +7.8 %), reflecting the trade-off between protection and upside participation.
• Top sector exposures: Technology ≈ 27 %, Health Care ≈ 16 %, Financials ≈ 14 %, mirroring the underlying large-cap index composition.
These figures suggest the ETF’s performance is closely tied to macro drivers such as U.S. GDP growth (projected 2.1 % YoY) and Federal Reserve policy (current policy rate 5.25 %). A slowdown in earnings growth or a sharp rise in volatility would likely increase the value of the buffer, while a strong equity rally would cap upside gains.
For a deeper, data-rich assessment of how IVVM’s buffer mechanics interact with sector-level risk, you may want to explore ValueRay’s quantitative dashboards.
What is the price of IVVM shares?
Over the past week, the price has changed by +0.06%, over one month by +0.09%, over three months by +2.73% and over the past year by +12.36%.
Is IVVM a buy, sell or hold?
What are the forecasts/targets for the IVVM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 37.6 | 7% |
IVVM Fundamental Data Overview February 05, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 145.9m USD (145.9m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 145.9m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 145.9m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.28% (E(145.9m)/V(145.9m) * Re(8.28%) + (debt-free company))
Discount Rate = 8.28% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)